Magdalena Zychowska

Smetna Street 12
Krakow, MA 31343, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.

Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 04, 2018

Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.

Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.

Journal: Frontiers in immunology

Published: November 08, 2017

Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.

Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.

Journal: International immunopharmacology

Published: July 19, 2017

Dataset of botulinum toxin A influence on interleukins under neuropathy.

Dataset of botulinum toxin A influence on interleukins under neuropathy.

Journal: Data in brief

Published: September 13, 2016

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.

Journal: European journal of pharmacology

Published: July 25, 2016

Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy.

Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy.

Journal: Anesthesiology

Published: July 09, 2016

PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.

PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.

Journal: PloS one

Published: March 11, 2015

The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy.

The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy.

Journal: Journal of diabetes research

Published: November 28, 2014

The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.

The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.

Journal: European journal of pharmacology

Published: June 04, 2014

Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies.

Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies.

Journal: Pharmacological reports : PR

Published: July 15, 2013

Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies.

Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies.

Journal: Pharmacological reports : PR

Published: July 15, 2013

Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.

Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.

Journal: Neuropharmacology

Published: March 08, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026